Skip to content

Maintenance Interpersonal Psychotherapy for Sustaining Remission of Depression

Maintenance Psychotherapies in Recurrent Depression: Study II

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00227981
Enrollment
93
Registered
2005-09-28
Start date
1995-03-31
Completion date
2001-03-31
Last updated
2013-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Depression Relapse, Maintenance Therapy

Brief summary

This study will evaluate the effectiveness of maintenance interpersonal psychotherapy (IPT) in preventing relapse of depression in women who have required combined psychotherapy and pharmacotherapy treatment to obtain a remission of depression symptoms.

Detailed description

Depression is a serious medical illness that can recur more than once in a person's lifetime. Effective treatment methods are needed to maintain a state of remission in people who have had prior episodes of depression. IPT is a brief and highly structured type of psychotherapy that addresses interpersonal issues associated with depression. Previous studies have shown that it is an effective method for treating depression. This study will evaluate the effectiveness of maintenance ITP in preventing relapse of depression in women who have required combined psychotherapy and pharmacotherapy treatment to obtain remission of depressive symptoms. Participants in this open label study will be recruited from a previous study, Maintenance Psychotherapy in Recurrent Depression: Study I. In this study participants will initially receive weekly sessions of IPT as well as medication treatment with fluoxetine. Any participants who do not reach remission of depressive symptoms after 6 weeks will be given other standard treatments for depression. Once remission of depressive symptoms is reached, participants will continue receiving weekly IPT and fluoxetine treatment for 20 weeks. After 20 weeks, fluoxetine treatment will be discontinued, and all participants will receive IPT alone for 6 weeks before entering the maintenance phase of the study. Upon entrance into this phase, participants will be randomly assigned to receive IPT weekly, biweekly, or monthly for 18 months. Functioning and depressive symptoms will be assessed at Month 24.

Interventions

BEHAVIORALInterpersonal Psychotherapy
DRUGFluoxetine

Sponsors

University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Met all entry criteria for the parent study, Maintenance Psychotherapy in Recurrent Depression, Study I * Began IPT as outlined in the parent study * Demostrated compliance with IPT sessions during the parent study * Exhibits less than a 50% reduction in score on the Hamilton Rating Scale for Depression after 12 weeks of psychotherapy or fails to meet stabilization criteria after 24 weeks of psychotherapy during the parent study

Exclusion criteria

* Any unstable medical illness

Design outcomes

Primary

MeasureTime frame
Score on the Hamilton Rating Scale for Depression (measured at Month 24)

Secondary

MeasureTime frame
Score on the Beck Depression Inventory
Score on the Global Assessment of Functioning (measured at Month 24)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026